SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-335258
Filing Date
2018-11-27
Accepted
2018-11-27 16:34:59
Documents
4
Period of Report
2018-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d647325d8k.htm 8-K 31207
2 EX-10.1 d647325dex101.htm EX-10.1 67245
3 EX-99.1 d647325dex991.htm EX-99.1 10227
4 GRAPHIC g647325img001.jpg GRAPHIC 11559
  Complete submission text file 0001193125-18-335258.txt   126168
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 181203399
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1